Gene · 23705
Papers3,480
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 3,480
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cancer stem cell-immune cell crosstalk in breast tumor microenvironment: a determinant of therapeutic facet. | Front Immunol | 2023 | 38090567 | PubTator, text mining | PubMed |
| Identification of angiogenesis-related genes in diabetic foot ulcer using machine learning algorithms. | Heliyon | 2023 | 38076120 | PubTator, text mining | PubMed |
| Antitumor Effect of Poplar Propolis on Human Cutaneous Squamous Cell Carcinoma A431 Cells. | Int J Mol Sci | 2023 | 38069077 | PubTator, text mining | PubMed |
| An Optimized Method to Culture Human Primary Lung Tumor Cell Spheroids. | Cancers (Basel) | 2023 | 38067281 | PubTator, text mining | PubMed |
| Identification and validation of M2 macrophage-related genes in endometriosis. | Heliyon | 2023 | 38058639 | PubTator, text mining | PubMed |
| Electroacupuncture for mild-to-moderate dry eye: study protocol for a multicentre, randomised, single-blind, sham-controlled trial. | BMJ Open | 2023 | 38056935 | PubTator, text mining | PubMed |
| AURKAIP1 actuates tumor progression through stabilizing DDX5 in triple negative breast cancer. | Cell Death Dis | 2023 | 38040691 | PubTator, text mining | PubMed |
| Anti-atherosclerosis mechanisms associated with regulation of non-coding RNAs by active monomers of traditional Chinese medicine. | Front Pharmacol | 2023 | 38026969 | PubTator, text mining | PubMed |
| Human Schwann Cells in vitro II. Passaging, Purification, Banking, and Labeling of Established Cultures. | Bio Protoc | 2023 | 38023793 | PubTator, text mining | PubMed |
| Human Schwann Cells in vitro I. Nerve Tissue Processing, Pre-degeneration, Isolation, and Culturing of Primary Cells. | Bio Protoc | 2023 | 38023787 | PubTator, text mining | PubMed |
| Molecular Epidemiology of Carbapenem Resistant Klebsiella Pneumoniae in Northern China: Clinical Characteristics, Antimicrobial Resistance, Virulence and Geographic Distribution. | Infect Drug Resist | 2023 | 38023401 | PubTator, text mining | PubMed |
| Triple-negative breast cancer: from none to multiple therapeutic targets in two decades. | Front Oncol | 2023 | 38023167 | PubTator, text mining | PubMed |
| Exosomal non-coding RNAs in glioma progression: insights into tumor microenvironment dynamics and therapeutic implications. | Front Cell Dev Biol | 2023 | 38020906 | PubTator, text mining | PubMed |
| Elemental Composition of Betel Leaves Using a Novel Optical Spectroscopic Technique. | Asian Pac J Cancer Prev | 2023 | 38019225 | PubTator, text mining | PubMed |
| HIF-1α-Induced Mitophagy Regulates the Regenerative Outcomes of Stem Cells in Fat Transplantation. | Cell Transplant | 2023 | 38009534 | PubTator, text mining | PubMed |
| Characterization of the Efficacy of a Split Swine Influenza A Virus Nasal Vaccine Formulated with a Nanoparticle/STING Agonist Combination Adjuvant in Conventional Pigs. | Vaccines (Basel) | 2023 | 38006039 | PubTator, text mining | PubMed |
| Recent Advances in Drug Discovery for Triple-Negative Breast Cancer Treatment. | Molecules | 2023 | 38005235 | PubTator, text mining | PubMed |
| First Report on Leptospira Species Isolated from Patients in Slovenia. | Microorganisms | 2023 | 38004750 | PubTator, text mining | PubMed |
| Exploring Therapeutic Avenues in Lung Cancer: The Epigenetic Perspective. | Cancers (Basel) | 2023 | 38001653 | PubTator, text mining | PubMed |
| TBXT dose sensitivity and the decoupling of nascent mesoderm specification from EMT progression in 2D human gastruloids. | bioRxiv | 2023 | 37986746 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23705/papers?page=10